Performa HargaHarga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)3.11
Harga Terendah (52 Minggu)2.96
Latar Belakang Perusahaan
Perusahaan yang mengembangkan terapi inovatif untuk penyakit metabolik, hati, dan kondisi inflamasi.
Summary
Valuation Information
Current PE Ratio (TTM)-3.29
Forward PE Ratio8.18
Current Price to Book Value1.38
Current Price to Sales-
EV to Revenue8370.63
EV to EBITDA11.93
PEG Ratio-
Per Share
Current EPS (Annualized)-0.92
Diluted EPS (TTM)-0.92
Revenue Per Share0
Current Book Value Per Share2.18
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date2017-01-20
Dividend Payment Date2018-09-14
Income Statement
EBITDA-96103000
Profit Margin0
Operating Margin-2672.47
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
